Lv2
162 积分 2023-04-12 加入
Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade
2天前
已完结
Oncolytic virus VG161 in refractory hepatocellular carcinoma
2天前
已完结
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
3天前
已完结
Therapy with oncolytic viruses: progress and challenges
3天前
已完结
Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization
11天前
已完结
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
11天前
已完结
Delivering living medicines with biomaterials
1个月前
已完结
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
2个月前
已完结
Neutrophil diversity and plasticity in tumour progression and therapy
2个月前
已完结
Unmasking the Many Faces of Tumor-Associated Neutrophils and Macrophages: Considerations for Targeting Innate Immune Cells in Cancer
2个月前
已完结
皖公网安备34019202002308
